I. Cabo López

Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

R. Yáñez Baña, M. G. Alonso Losada, D. Santos García, 2021, Brain sciences.

High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson’s disease patients

I. Parees, J. Kulisevsky, P. Martínez-Martín, 2019, Journal of Neural Transmission.

Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study

C. Labandeira, R. Yáñez Baña, M. G. Alonso Losada, 2022, Brain sciences.

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort.

I. Parees, J. Kulisevsky, P. Martínez-Martín, 2019, Parkinsonism & related disorders.

The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype

I. Parees, J. Kulisevsky, P. Martínez-Martín, 2020, Neurological Sciences.

Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR

C. Labandeira, R. Yáñez Baña, M. G. Alonso Losada, 2021, Advances in Therapy.

Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study

R. Yáñez Baña, M. G. Alonso Losada, D. Santos García, 2021, Neurological Sciences.

Pain Improvement in Parkinson’s Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study

R. Yáñez Baña, M. G. Alonso Losada, D. Santos García, 2021, Journal of personalized medicine.